The agonist SR 146131 and the antagonist SR 27897 occupy different sites on the human CCK 1 receptor

By Gouldson P.   Legoux P.   Carillon C.   Delpech B.   Le Fur G.   Ferrara P.   Shire D.  

European Journal of Pharmacology, Vol. 400, Iss. 2, 2000-07 ,pp. : 185-194

Elsevier

Access to resources Recommend Favorite

Contrasting roles of Leu 356 in the human CCK 1 receptor for antagonist SR 27897 and agonist SR 146131 binding

By Gouldson P.   Legoux P.   Carillon C.   Delpech B.   Le Fur G.   Ferrara P.   Shire D.  

European Journal of Pharmacology, Vol. 383, Iss. 3, 1999-11 ,pp. : 339-346

Elsevier

Access to resources Recommend Favorite

Essential role of extracellular charged residues of the human CCK 1 receptor for interactions with SR 146131, SR 27897 and CCK-8S

By Gouldson P.   Legoux P.   Carillon C.   Dumont X.   Le Fur G.   Ferrara P.   Shire D.  

European Journal of Pharmacology, Vol. 389, Iss. 2, 2000-02 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Characterisation of the effects of SR146131, a novel non-peptide CCK 1 receptor agonist, on IMR-32 human neuroblastoma cells

By Schaeffer P.   Nestor A.L.   Prabonnaud V.   Bachy A.   Laplace M.C.   Keane P.E.   Bignon E.   Herbert J.M.  

European Journal of Pharmacology, Vol. 397, Iss. 2, 2000-06 ,pp. : 303-310

Elsevier

Access to resources Recommend Favorite

Erratum to: ''Enhanced -opioid receptor-mediated antinociception in -opioid receptor-deficient mice'' - [Eur. J. Pharmacol. 387 (2000) 163-169] 1

By Qiu C.   Sora I.   Ren K.   Uhl G.   Dubner R.  

European Journal of Pharmacology, Vol. 397, Iss. 1, 2000-05 ,pp. : 227-227

Elsevier

Access to resources Recommend Favorite